Allogeneic somatic cell therapy: process development challenges and future opportunities.
Cell-replacement therapy has emerged during the past decade as a potential solution for many diseases. However, for this promise to be fulfilled, numerous process development challenges specific to these products need to be overcome. This editorial overview highlights some key observations derived from research on an allogeneic somatic cell therapy product for the treatment of Parkinson's disease.
Fawaz
Farah S
FS
Hermiston
Terry W
TW
Dinter
Harald
H
D000818:Animals; D049109:Cell Proliferation; D064987:Cell- and Tissue-Based Therapy / Q000379:methods* / Q000639:trends*; D006801:Humans; D013997:Time Factors; D020858:Tissue and Organ Harvesting